Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02960022
Title A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.

prostate cancer


Abiraterone + Enzalutamide + Prednisone


Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

No variant requirements are available.